首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months
【2h】

Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months

机译:膝关节骨关节炎患者血小板富含血小板的血浆与透明质酸的内部内注射:6个月的初步随访结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to compare the clinical and economic benefits of intra-articular injections of platelet-rich plasma (PRP) and hyaluronic acid (HA) in Chinese patients with knee osteoarthritis (OA). A total of 86 patients (42 treated with PRP and 44 with HA) were treated with three weekly intra-articular injections. The inclusion criteria included patients between 18 and 75 years of age, with chronic knee pain or swelling lasting >3 months and X-ray findings of degenerative joint alterations according to the Kellgren-Lawrence score grade I-III. Clinical examinations were performed before treatment, at 1- and 6-month post-injection intervals. International Knee Documentation Committee subjective, Western Ontario and McMaster Universities and visual analogue scale scores were determined at each examination. Adverse reactions, average cost, treatment time and patient satisfaction were also recorded. Compared with patients injected with HA, PRP was found to be associated with increased and more severe post-injection pain and swelling, where the duration of adverse reactions was greater in the PRP group (P=0.02). During the follow-up evaluations, both groups showed statistically significant improvements in all clinical scores from pre-injection to 1- and 6-month assessments (P<0.05). However, no significant inter-group (PRP vs. HA) differences were observed in the clinical scores between the two follow-up time points. There were also no significant differences in clinical score between the groups with regards to the Kellgren-Lawrence grade I, II or III. The average cost of PRP injections was 22.8X that of HA administration and the average treatment time was 5X that of HA, but there was no significant difference in patient satisfaction. These preliminary results indicate that although PRP injections can significantly improve clinical outcome in patients with knee OA, PRP is not any more effective compared with HA. Furthermore, PRP injections are associated with higher costs and treatment times. Therefore, additional clinical studies are required before PRP injections can be considered as a first-line treatment option for knee OA.
机译:本研究的目的是将关节内注射血小板血浆(PRP)和透明质酸(HA)中的临床和经济效益进行比较,在中国膝关节骨关节炎(OA)中的中国患者。每周三个每周内注射一次,共有86名患者(用PRP和44次处理)治疗。纳入标准包括18至75岁的患者,慢性膝关节疼痛或肿胀持续> 3个月和X射线调查结果,根据Kellgren-Lawrence得分等级I-III。在治疗前进行临床检查,每次注射后的1-和6个月。国际膝关节文件主观,在每次考试时确定西部的安大略省和麦克马斯大学和麦克马斯大学和视觉模拟规模分数。还记录了不良反应,平均成本,治疗时间和患者满意度。与注射HA的患者相比,PRP被发现与增加和更严重的注射后疼痛和肿胀相关,在PRP组中不良反应的持续时间更大(P = 0.02)。在后续评估期间,两组在预注射到1次和6个月评估的所有临床评分中显示出统计学上显着的改善(P <0.05)。然而,在两个后续时间点之间的临床评分中没有观察到显着的群体间(PRP与HA)差异。对于Kellgren-Lawrence等级I,II或III的群体之间的临床评分也没有显着差异。 PRP注射的平均成本为HA管理的22.8倍,平均治疗时间为HA的5倍,但患者满意度没有显着差异。这些初步结果表明,尽管PRP注射可以显着改善膝关节OA患者的临床结果,但与HA相比,PRP并不更有效。此外,PRP注射与成本和治疗时间更高。因此,在PRP注射可以被认为是膝关节OA的一线处理选项之前需要额外的临床研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号